THE DOSE
your daily dose of Innovative, trending, and groundbreaking stories from across the cosmos.
FDA on Board with Psilocybin as a “BreakThrough Therapy”
FDA is helping to speed up the process of researching and approving psilocybin, MDMA, and Ketamine for breakthrough treatments in patients with Depression, Anxiety, PTSD, and even addiction.
